Can a pregnant woman receive the Measles, Mumps, and Rubella (MMR) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pregnant women should not receive the MMR (measles, mumps, rubella) vaccine due to the theoretical risk it poses to the developing fetus, particularly the rubella component which could potentially cause congenital rubella syndrome if given during pregnancy. This recommendation is based on the precautionary principle, as no cases of congenital rubella syndrome have been documented from vaccine administration, but the theoretical risk outweighs the benefit during pregnancy since these infections can usually be delayed until after delivery 1.

Key Considerations

  • The MMR vaccine is a live attenuated vaccine, and its administration during pregnancy is contraindicated due to the potential risk to the fetus 1.
  • If a woman is planning pregnancy, she should receive the MMR vaccine at least one month before conception if she is not already immune.
  • For pregnant women who are exposed to measles or mumps, immune globulin may be recommended instead.
  • After delivery, women with no evidence of immunity should receive the MMR vaccine before hospital discharge.
  • The standard MMR dose is 0.5 mL administered subcutaneously, typically given as two doses separated by at least 28 days.

Counseling and Pregnancy Testing

  • Women of childbearing age should be asked if they are pregnant or intend to become pregnant in the next 4 weeks before administering the MMR vaccine 1.
  • Routine pregnancy testing of women of childbearing age before administering a live-virus vaccine is not recommended 1.
  • If a pregnant woman is inadvertently vaccinated or if she becomes pregnant within 4 weeks after MMR vaccination, she should be counseled regarding the theoretical basis of concern for the fetus; however, MMR vaccination during pregnancy should not ordinarily be a reason to terminate pregnancy 1.

From the Research

Vaccination During Pregnancy

  • The MMR vaccine is a live and/or live-attenuated virus vaccine, which is generally contraindicated during pregnancy due to a theoretical risk to the fetus 2, 3.
  • According to the Advisory Committee on Immunization Practices (ACIP), live attenuated vaccines, including MMR, are contraindicated during pregnancy 4.
  • The American College of Obstetricians and Gynecologists (ACOG) recommends that pregnant women receive inactivated virus, bacterial vaccines, or toxoids, but does not mention the MMR vaccine as a recommended vaccine during pregnancy 5, 6.
  • It is recommended that women who are or will be pregnant during influenza season receive an annual influenza vaccine, and all pregnant women should receive a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine during each pregnancy 5, 6.

MMR Vaccine Specifics

  • The MMR vaccine is not recommended for pregnant women, and women who have inadvertently received the vaccine during pregnancy should not be counseled to terminate the pregnancy due to a teratogenic risk 2.
  • Non-pregnant women immunized with a live or live-attenuated vaccine, including MMR, should be counseled to delay pregnancy for at least four weeks 2.
  • Women who are breastfeeding can still be immunized with live or killed vaccines, including MMR 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Immunization in pregnancy.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2008

Research

Immunizations during pregnancy: How, when and why.

European journal of obstetrics, gynecology, and reproductive biology, 2019

Research

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2013

Research

ACOG Committee Opinion No. 741: Maternal Immunization.

Obstetrics and gynecology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.